EEA1 and metastatic neoplasm: The significant changes to APPL1, RAB5A and EEA1 gene expression in prostate tissue from aggressive disease compared to normal tissue or indolent-disease tissue indicates that these biomarkers have significant potential to monitor disease progression and to stratifying patients at risk of progressive and or metastatic disease.